22
Views
1
CrossRef citations to date
0
Altmetric
Original Papers

Morbidity and Mortality after Induction Chemotherapy Followed by Surgery in IIIa-N2 non Small Cell Lung Cancer

, , , , , , & show all
Pages 333-339 | Published online: 11 Mar 2016

References

  • Rosell R., Gómez-Codina J., Camps C. et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med, 1994, 330: 153–8.
  • Roth J. A., Fossella F., Komaki R. et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst, 1994, 86: 673–80.
  • Mountain C. F. Revisions in the International System for Staging Lung Cancer. Chest, 1997, 111: 1710–7.
  • Venuta F., Anile M., Diso D. et al. Operative complications and early mortality after induction therapy for lung cancer. Eur J Cardiothorac Surg, 2007, 31: 714–7.
  • Stamatis G., Djuric D., Eberhardt W. et al. Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated patients. Eur J Cardiothorac Surg, 2002, 22: 292–7.
  • Depierre A., Milleron B., Moro-Sibilot D. et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and Ilia non-small-cell lung cancer. J Clin Oncol, 2002, 20: 247–53.
  • Roberts J. R., Eustis C., Devore R. et al. Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancer. Ann Thorac Surg, 2001, 72: 885–8.
  • Martin J., Ginsberg R. J., Abolhoda A. et al. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann Thorac Surg, 2001, 72: 1149–54.
  • Siegenthaler M. P., Pisters K. M., Merriman K. W. et al. Preoperative chemotherapy for lung cancer does not increase surgical morbidity. Ann Thorac Surg, 2001, 71: 1105–11.
  • Perrot E., Guibert B., Mulsant P. et al. Preoperative chemotherapy does not increase complications after nonsmall cell lung cancer resection. Ann Thorac Surg, 2005, 80: 423–7.
  • Charlson M. E., Pompei P., Ales K. L., Mackenzie C. R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis, 1987, 40: 373–83.
  • Colinet B., Jacot W., Bertrand D. et al. A new simplified co-morbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson’s index. Br J Cancer, 2005, 93: 1098–105.
  • Copeland G. P., Jones D., Walters M. POSSUM: a scoring system for surgical audit. Br J Surg, 1991, 78: 356–70.
  • Lardinois D., De Leyn P., Van Schil P., Rami-Porta R., Waller D., Passlick B., Zielinski M., Lerut T., Weder W. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg, 2006, 30: 787–92.
  • Rami-Porta R., Wittekind C., Goldstraw P. Complete resection in lung cancer surgery: proposed definition. Lung Cancer, 2005, 49: 25–33.
  • Fowler W. C., Langer C. J., Curran W. J. Jr., Keller S. M. Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg, 1993, 55: 986–9.
  • Bach P. B., Cramer L. D., Schrag D. et al. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med, 2001, 345: 181–8.
  • Deslauriers J., Grégoire J., Jacques L. F., Piraux M. Sleeve pneumonectomy. Thorac Surg Clin, 2004, 14: 183–90.
  • Brunelli A., Monteverde M., Borri A. et al. Predictors of prolonged air leak after pulmonary lobectomy. Ann Thorac Surg, 2004, 77: 1205–10.
  • Stolz A. J., Schützner J., Lischke R., Simonek J., Pafko P. Predictors of prolonged air leak following pulmonary lobectomy. Eur J Cardiothorac Surg, 2005, 27: 334–6.
  • Serra-Mitjans M., Belda-Sanchis J., Rami-Porta R. Surgical sealant for preventing air leaks after pulmonary resections in patients with lung cancer. Cochrane Database Syst Rev, 2005, 20: CD003051.
  • Sfyridis P. G., Kapetanakis E. I., Baltayiannis N. E. et al. Bronchial stump buttressing with an intercostal muscle flap in diabetic patients. Ann Thorac Surg, 2007, 84: 967–71.
  • Ferguson M. K., Vigneswaran WT. Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease. Ann Thorac Surg, 2008, 85: 1158–64.
  • Brunelli A., Fianchini A., Gesuita R., Carle F. POSSUM scoring system as an instrument of audit in lung resection surgery. Physiological and operative severity score for the enumeration of mortality and morbidity. Ann Thorac Surg, 1999, 67: 329–31.
  • Asmis T. R., Ding K., Seymour L. et al. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials. J Clin Oncol, 2008, 26: 54–9.
  • Wang e. Y., Lin Y. S., Tzao C. et al. Comparison of Charlson comorbidity index and Kaplan-Feinstein index in patients with stage I lung cancer after surgical resection. Eur J Cardiothorac Surg, 2007, 32: 877–81.
  • Jacot W., Colinet B., Bertrand D. et al. Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients. Ann Oncol, 2008, 19: 1458–64.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.